Whole-Person Risk Screening in Primary Care: An Evidence-Based Review

Abstract

Whole-person risk screening in primary care extends beyond traditional disease-specific approaches by integrating biological, psychological, social, and behavioral determinants of health. This review synthesizes recent scientific evidence on the epidemiology, pathophysiology, risk factors, clinical features, diagnostic strategies, management, emerging therapies, and current guideline recommendations for whole-person risk assessment. The goal is to provide clinicians with a comprehensive, practical framework for implementing whole-person screening, thereby improving patient outcomes, reducing care fragmentation, and enhancing preventive healthcare delivery.

Introduction

The paradigm of primary care is shifting from a disease-centric model to a holistic approach that considers the full spectrum of determinants impacting patient health. Whole-person risk screening is designed to identify not only biomedical risks but also psychosocial, behavioral, and environmental factors that contribute to morbidity and mortality. This comprehensive approach aligns with the growing recognition of multimorbidity and the need for individualized care plans. The present review examines the scientific basis and clinical application of whole-person risk screening, emphasizing its relevance for contemporary primary care practice.

Epidemiology / Disease Burden

Chronic diseases, including cardiovascular disease, diabetes, cancer, and mental health disorders, account for the majority of morbidity, mortality, and healthcare expenditures globally. Multimorbidity is increasingly prevalent, particularly among aging populations. Epidemiological studies underscore that up to 25% of adults in high-income countries have two or more chronic conditions, with higher rates observed in socioeconomically disadvantaged groups. Traditional risk screening often fails to capture the interplay between coexisting conditions and social determinants, resulting in missed opportunities for early intervention. Whole-person risk screening addresses these gaps by providing a more complete assessment of population health needs, supporting both prevention and early detection strategies.

Pathophysiology

The pathophysiology underlying whole-person risk is multifactorial, involving complex interactions between genetic predisposition, environmental exposures, psychosocial stressors, and behavioral patterns. Chronic stress, for example, can drive neuroendocrine dysregulation, inflammation, and metabolic disturbances, thereby increasing susceptibility to a range of diseases. Social isolation, adverse childhood experiences, and health literacy deficits further modulate biological pathways and influence disease expression. Understanding these mechanisms highlights the necessity of integrated risk assessment tools capable of evaluating the cumulative impact of diverse determinants on health outcomes.

Risk Factors

Whole-person risk screening encompasses traditional biomedical risk factors such as hypertension, dyslipidemia, family history, and obesity as well as psychosocial and behavioral elements, including depression, anxiety, substance use, social support, socioeconomic status, and health behaviors (diet, physical activity, sleep). Environmental exposures, health access barriers, and cultural factors may also play significant roles. Tools such as the INTERHEART Risk Score, QRISK3, and the WHO STEPS approach have evolved to incorporate expanded risk domains, yet ongoing research seeks to refine these instruments for routine primary care application.

Clinical Features

Patients with elevated whole-person risk often present with a constellation of symptoms and signs that may not fit neatly into a single disease category. Common clinical features include fatigue, mood disturbances, sleep disruption, and non-specific somatic complaints. Multimorbidity frequently manifests as overlapping symptoms, medication interactions, and complex care needs. Recognizing these patterns is crucial for timely identification and tailored intervention. The clinician's role extends to eliciting comprehensive histories and contextualizing findings within each individual\'s broader life circumstances.

Diagnosis

Diagnosis in whole-person risk screening involves validated assessment tools, structured interviews, and multidimensional health questionnaires. Instruments such as the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder scale (GAD-7), and social determinants of health checklists are increasingly used alongside traditional risk calculators. Laboratory and imaging studies remain important but are interpreted within the context of psychosocial and behavioral risk profiles. Electronic health record (EHR) integration and decision support algorithms facilitate systematic screening, but clinician judgment remains paramount in synthesizing findings and prioritizing care.

Treatment & Management

Management of patients identified through whole-person screening is inherently multidisciplinary, involving medical, behavioral, and social interventions. Care models such as the patient-centered medical home (PCMH) and collaborative care emphasize coordinated, longitudinal support. Evidence-based interventions include lifestyle modification, pharmacotherapy, behavioral counseling, and social resource navigation. Motivational interviewing and shared decision-making are essential to engage patients in their care plans. Regular follow-up and care plan adaptation are required to address evolving risk profiles and patient preferences.

Recent Advances / Emerging Therapies

Recent advances in whole-person risk screening include the development of digital health platforms, artificial intelligence (AI)-driven risk prediction tools, and integration of patient-reported outcomes. Machine learning algorithms now enable more personalized risk stratification by analyzing diverse data streams from EHRs, wearable devices, and social determinants databases. Emerging therapies address not only biomedical needs but also mental health and social care gaps, with community health workers, telehealth, and behavioral health integration showing promise in improving outcomes for high-risk populations.

Guideline Recommendations

Major guidelines from organizations such as the U.S. Preventive Services Task Force (USPSTF), National Institute for Health and Care Excellence (NICE), and World Health Organization (WHO) increasingly advocate for whole-person approaches to risk assessment and management. These bodies recommend routine screening for depression, substance use, social needs, and cardiovascular risk factors in primary care, with a focus on individualized care planning and interdisciplinary collaboration. Implementation science research supports the use of structured protocols and team-based care to optimize the impact of whole-person screening initiatives.

Conclusion

Whole-person risk screening represents a transformative approach in primary care, offering a nuanced understanding of patient vulnerability and opportunity for proactive intervention. By integrating biomedical, psychosocial, and behavioral risk domains, clinicians can deliver more effective, equitable, and patient-centered care. Ongoing research, technological innovation, and policy support are essential to realize the full potential of whole-person risk screening and achieve meaningful improvements in population health.